Feedback controlled, ultra-high-precision drug delivery

我们已经证明了有史以来第一个闭环反馈控制血浆药物水平的例子 通过实时体内药物测量得到信息。我们使用一种传感架构实现了这一点， 与靶分子的化学反应性无关，至少在理论上， 可推广到任何药物。在这里，我们提出了一个研究和发展计划，旨在翻译这一点， 创新突破，成为适用于药理学研究和临床的强大新工具 实践通过提高（数量级）我们可以控制体内药物水平的精度， 提出的技术将使药代动力学成为实验可控参数， 研究人员更精确地绘制药代动力学和临床结果之间的关系， 消除作为混杂实验变量的药代动力学不一致性，并准确模拟 动物模型中的人体药代动力学。最终，这种技术可以用于临床， 根据患者不断变化的代谢情况，随时优化给药， 治疗的好处最大化，而其风险最小化。

We have demonstrated the first ever example of closed-loop feedback control over plasma drug levels informed by real-time in-vivo drug measurements. We achieved this using a sensing architecture that is independent of the chemical reactivity of the target molecule, rendering the approach, at least in theory, generalizable to any drug. Here we propose a research and development program aimed at translating this innovative breakthrough into a powerful new tool applicable to both pharmacological research and clinical practice. By improving (by orders of magnitude) the precision with which we can control in-vivo drug levels, the proposed technology would render pharmacokinetics an experimentally controllable parameter, allowing researchers to more precisely map the relationships between pharmacokinetics and clinical outcomes, to eliminate pharmacokinetic inconsistency as a confounding experimental variable, and to accurately simulate human pharmacokinetics in animal models. Ultimately, such a technology could be used in the clinic where, by optimize dosing moment-to-moment in response to a patient's changing metabolism, it would ensure that a therapy's benefits are maximized while its risks are minimized.